Pro Medicus Secures Major 10-Year Contract with Trinity Health

3 min read | November 28, 2024 03:02 PM AEDT | By Team Kalkine Media

Google News:

Pro Medicus Secures Major 10-Year Contract with Trinity Health — Image source: shutterstock

Recent News

Banks Hold Firm While Tech Stumbles: What The ASX Charts Reveal

Northern Star (ASX:NST) At A Golden Crossroads: Are Gold Miners Just G...

ASX Tech Takes a Beating as the Fed Slams the Door on Rate Cuts

Why Insurers and Financial Stocks Are Drawing Fresh Attention

Make Kalkine Media
My Trusted Source

Highlights

Pro Medicus announces a significant $330 million contract with Trinity Health.

The 10-year deal includes migrating systems to the Visage 7 platform.

Shares of Pro Medicus saw a strong uptick following the announcement.

Pro Medicus (ASX:PME) has taken a significant step forward with its latest announcement of a $330 million, 10-year contract with Trinity Health, a prominent not-for-profit healthcare organization in the United States. This landmark deal, facilitated through Pro Medicus’ subsidiary Visage Imaging, aims to overhaul Trinity Health’s imaging systems and implement the Visage 7 platform across its extensive network.

The Agreement's Scope

Trinity Health, a widely recognized name in the healthcare sector, operates across 26 states with a vast network that includes 93 hospitals, 107 continuing care facilities, and 142 urgent care centers. Under this agreement, the legacy systems at these facilities will transition to Pro Medicus’ advanced Visage 7 platform, which is known for enhancing imaging efficiency and streamlining workflows.

This contract positions Trinity Health as the largest customer for Pro Medicus to date, marking a pivotal moment in the company’s global expansion. The migration to Visage 7 is expected to provide Trinity with a scalable and robust imaging platform, enhancing care delivery across its facilities.

Leadership's Perspective

Pro Medicus CEO Dr. Sam Hupert described Trinity Health as a groundbreaking client due to its extensive national presence. “This is a significant milestone for Pro Medicus, representing both our largest customer to date and our first with a national footprint,” stated Dr. Hupert.

The CEO also highlighted how the deal underscores the trust large-scale healthcare organizations place in the company’s technology and expertise.

Market Response

Following the announcement, shares of Pro Medicus surged over nine percent, reaching $249.94. This strong market response reflects confidence in the company’s ability to execute such transformative projects while maintaining its position as a leader in healthcare imaging solutions.

This deal not only solidifies the company’s foothold in the U.S. market but also sets a benchmark for future large-scale contracts. The long-term nature of the agreement ensures sustained growth and recurring revenue for the company.

Pro Medicus continues to demonstrate its commitment to innovation and quality in healthcare technology, with this contract further emphasizing its role in transforming the imaging landscape globally.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.